Fennec Pharmaceuticals Inc.
FENC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$436 | -$16,045 | -$23,714 | -$17,346 |
| Dep. & Amort. | $959 | $287 | $149 | $16 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,061 | $5,354 | $4,220 | $4,015 |
| Change in WC | -$7,329 | -$8,166 | -$509 | -$138 |
| Other Non-Cash | $28,725 | $1,427 | $1,796 | -$769 |
| Operating Cash Flow | $26,980 | -$17,143 | -$18,058 | -$14,222 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$13,000 | $5,000 | $20,173 | $4,986 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$176 | -$78 | -$194 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$439 | $1,716 | $753 | -$8 |
| Financing Cash Flow | -$13,615 | $6,638 | $20,732 | $4,978 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $13,365 | -$10,505 | $2,674 | -$9,244 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,269 | $23,774 | $21,100 | $30,344 |
| End Cash | $26,634 | $13,269 | $23,774 | $21,100 |
| Free Cash Flow | $26,980 | -$17,143 | -$18,058 | -$14,222 |